Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoter
Keyword(s):
2014 ◽
Vol 86
(7)
◽
pp. 1129-1140
◽
Keyword(s):
Keyword(s):
2006 ◽
Vol 43
(3)
◽
pp. 639-640
◽
2011 ◽
Vol 153
(2)
◽
pp. 233-234
◽
Keyword(s):